Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Population attributable fractions for late postnatal mother-to-child transmission of HIV-1 in Sub-Saharan Africa.

Chen YQ, Young A, Brown ER, Chasela CS, Fiscus SA, Hoffman IF, Valentine M, Emel L, Taha TE, Goldenberg RL, Read JS.

J Acquir Immune Defic Syndr. 2010 Jul;54(3):311-6. doi: 10.1097/QAI.0b013e3181d61c2e.

2.

Risk factors for late postnatal transmission of human immunodeficiency virus type 1 in sub-Saharan Africa.

Chasela C, Chen YQ, Fiscus S, Hoffman I, Young A, Valentine M, Emel L, Taha TE, Goldenberg RL, Read JS.

Pediatr Infect Dis J. 2008 Mar;27(3):251-6. doi: 10.1097/INF.0b013e31815b4960.

3.
4.

Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.

Kesho Bora Study Group, de Vincenzi I.

Lancet Infect Dis. 2011 Mar;11(3):171-80. doi: 10.1016/S1473-3099(10)70288-7. Epub 2011 Jan 13. Erratum in: Lancet Infect Dis. 2011 Mar;11(3):159. Read, Jennifer S [corrected to Read, Jennifer].

PMID:
21237718
6.

Maternal viral load and timing of mother-to-child HIV transmission, Bangkok, Thailand. Bangkok Collaborative Perinatal HIV Transmission Study Group.

Mock PA, Shaffer N, Bhadrakom C, Siriwasin W, Chotpitayasunondh T, Chearskul S, Young NL, Roongpisuthipong A, Chinayon P, Kalish ML, Parekh B, Mastro TD.

AIDS. 1999 Feb 25;13(3):407-14.

PMID:
10199232
7.

Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.

Sturt AS, Dokubo EK, Sint TT.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008440. doi: 10.1002/14651858.CD008440. Review.

PMID:
20238370
8.

Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohort studies. SEROGEST Cohort Group.

Mayaux MJ, Dussaix E, Isopet J, Rekacewicz C, Mandelbrot L, Ciraru-Vigneron N, Allemon MC, Chambrin V, Katlama C, Delfraissy JF, Puel J.

J Infect Dis. 1997 Jan;175(1):172-5.

PMID:
8985214
9.

Increased infant human immunodeficiency virus-type one free survival at one year of age in sub-saharan Africa with maternal use of highly active antiretroviral therapy during breast-feeding.

Marazzi MC, Nielsen-Saines K, Buonomo E, Scarcella P, Germano P, Majid NA, Zimba I, Ceffa S, Palombi L.

Pediatr Infect Dis J. 2009 Jun;28(6):483-7. doi: 10.1097/INF.0b013e3181950c56.

PMID:
19483516
10.

Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.

Mofenson LM, Lambert JS, Stiehm ER, Bethel J, Meyer WA 3rd, Whitehouse J, Moye J Jr, Reichelderfer P, Harris DR, Fowler MG, Mathieson BJ, Nemo GJ.

N Engl J Med. 1999 Aug 5;341(6):385-93.

11.

Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

Siegfried N, van der Merwe L, Brocklehurst P, Sint TT.

Cochrane Database Syst Rev. 2011 Jul 6;(7):CD003510. doi: 10.1002/14651858.CD003510.pub3. Review.

PMID:
21735394
12.
13.

Plasma viraemia in HIV-positive pregnant women entering antenatal care in South Africa.

Myer L, Phillips TK, Hsiao NY, Zerbe A, Petro G, Bekker LG, McIntyre JA, Abrams EJ.

J Int AIDS Soc. 2015 Jul 6;18:20045. doi: 10.7448/IAS.18.1.20045. eCollection 2015.

14.

Morbidity and mortality among a cohort of human immunodeficiency virus type 1-infected and uninfected pregnant women and their infants from Malawi, Zambia, and Tanzania.

Chilongozi D, Wang L, Brown L, Taha T, Valentine M, Emel L, Sinkala M, Kafulafula G, Noor RA, Read JS, Brown ER, Goldenberg RL, Hoffman I; HIVNET 024 Study Team.

Pediatr Infect Dis J. 2008 Sep;27(9):808-14. doi: 10.1097/INF.0b013e31817109a4.

15.

Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

Volmink J, Siegfried NL, van der Merwe L, Brocklehurst P.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD003510. Review. Update in: Cochrane Database Syst Rev. 2011;(7):CD003510.

PMID:
17253490
16.

Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load <500 copies/ml at delivery: a case-control study nested in the French perinatal cohort (EPF-ANRS CO1).

Tubiana R, Le Chenadec J, Rouzioux C, Mandelbrot L, Hamrene K, Dollfus C, Faye A, Delaugerre C, Blanche S, Warszawski J.

Clin Infect Dis. 2010 Feb 15;50(4):585-96. doi: 10.1086/650005.

PMID:
20070234
17.

Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.

Tonwe-Gold B, Ekouevi DK, Viho I, Amani-Bosse C, Toure S, Coffie PA, Rouet F, Becquet R, Leroy V, El-Sadr WM, Abrams EJ, Dabis F.

PLoS Med. 2007 Aug;4(8):e257.

18.

Easier said than done: World Health Organization recommendations for prevention of mother-to-child transmission of HIV-areas of concern.

Palombi L, Nielsen-Saines K, Giuliano M, Marazzi MC.

AIDS Res Hum Retroviruses. 2011 Aug;27(8):807-8. doi: 10.1089/AID.2010.0296. Epub 2011 Jan 17.

PMID:
21142813
19.

HIV-1 mother-to-child transmission and drug resistance among Brazilian pregnant women with high access to diagnosis and prophylactic measures.

Alcântara KC, Lins JB, Albuquerque M, Aires LM, Cardoso LP, Minuzzi AL, Stefani MM.

J Clin Virol. 2012 May;54(1):15-20. doi: 10.1016/j.jcv.2012.01.011. Epub 2012 Feb 6.

20.

Twelve-month follow-up of Six Week Extended Dose Nevirapine randomized controlled trials: differential impact of extended-dose nevirapine on mother-to-child transmission and infant death by maternal CD4 cell count.

Omer SB; Six Week Extended Dose Nevirapine (SWEN) Study Team.

AIDS. 2011 Mar 27;25(6):767-76. doi: 10.1097/QAD.0b013e328344c12a. Erratum in: AIDS. 2012 Nov 28;26(18):2427-8.

PMID:
21330912

Supplemental Content

Support Center